Product ID:100 3623,WKG SOL,KODAK INDUSTREX MANUAL DEVELOPER(SEE SUPPL)
MSDS Date:11/15/2000
FSC:6750
NIIN:01-321-4756
Status Code:A
MSDS Number: CLDSQ

EASTMAN KODAK COMPANY

343 STATE STREET
ROCHESTER, NY 14650
US

Emergency Phone: 716-722-5151

Info Phone: 800- 242-2424

Preparer: NOT PROVIDED

Cage: 19139

EASTMAN KODAK CO GOVERNMENT MARKETS CONTRACTS

ROCHESTER, NY 14650-1115 US

Telephone: 716-722-5151/(800) 242-2424

Cage: 19139

WATER

CAS: 7732-18-5

RTECS: ZC0110000

POTASSIUM SULFITE

CAS: 10117-38-1

RTECS: WT3530000

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED

SODIUM SULFITE

CAS: 7757-83-7

RTECS: WE2150000

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED

HYDROQUINONE

CAS: 123-31-9

RTECS: MX3500000

OSHA PEL 2 MG/M3

ACGIH TLV: 2 MG/M3

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

POTASSIUM ACETATE

CAS: 127-08-2

RTECS: AJ3325000

OSHA PEL NOT PROVIDED

ACGIH TLV: NOT PROVIDED

LD50 LC50 Mixture:NOT PROVIDED
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION: LOW HAZARD FOR RECOMMENDED
HANDLING. IN CONTACT WITH STRONG ACIDS OR IF HEATED, SULFITES MAY
LIBERATE SULFUR DIOXIDE GAS. SULFUR DIOXIDE GAS IS IRRITATING TO
RESPIRATORY TRACT. SOME ASTHMA TICS OR HYPERSENSITIVE INDIVIDUALS
MAY EXPERIENCE DIFFICULT BREATHING. EYES: CAUSES IRRITATION. SKIN:
CAUSES IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION BASED ON HUMAN
EXPERIENCE. MAY CAUSE SKIN DEP IGMENTATION. PROLONGED OR REPEATED
CONTACT MAY CAUSE DRYING, CRACKING, OR IRRITATION. INGESTION:
HARMFUL IF SWALLOWED.
Explanation of Carcinogenicity:CARCINOGENICITY CLASSIFICATION
(COMPONENTS PRESENT AT 0.1% OR MORE): - INTERNATIONAL AGENCY FOR
RESEARCH ON CANCER (IARC): HYDROQUINONE-GROUP 3. - AMERICAN
CONFERENCE OF GOVERNMENTAL INDUSTRIAL HYGIEN ISTS (ACGIH):
HYDROQUINONE A3. - NATIONAL TOXICOLOGY PROGRAM (NTP): NONE -
OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA): NONE
Effects of Overexposure:INHALATION: IN CONTACT WITH STRONG ACIDS OR IF
HEATED, SULFITES MAY LIBERATE SULFUR DIOXIDE GAS. SULFUR DIOXIDE
GAS IS IRRITATING TO RESPIRATORY TRACT. EYES: CAUSES IRRITATION.
SKIN: CAUSES IRRITATION . MAY CAUSE ALLERGIC SKIN REACTION BASED ON
HUMAN EXPERIENCE. MAY CAUSE SKIN DEPIGMENTATION. PROLONGED OR
REPEATED CONTACT MAY CAUSE DRYING, CRACKING, OR IRRITATION.
Medical Cond Aggravated by Exposure:SOME ASTHMATICS, HYPERSENSITIVE OR
SULFITE-SENSITIVE INDIVIDUALS MAY EXPERIENCE DIFFICULT BREATHING,
WHEEZING, CHEST TIGHTNESS, STOMACH UPSET, HIVES, FAINTNESS,
WEAKNESS AND DIARRHEA.

First Aid:INHALATION: IF SYMPTOMATIC, MOVE TO FRESH AIR. TREAT
SYMPTOMATICALLY. GET MEDICAL ATTENTION IF SYMPTOMS PERSIST. EYES:
IMMEDIATELY FLUSH WITH PLENTY OF WATER FOR AT LEAST 15 MINUTES. GET
MEDICAL ATTEN TION. SKIN: IMMEDIATELY FLUSH WITH PLENTY OF WATER
FOR AT LEAST 15 MINUTES WHILE REMOVING CONTAMINATED CLOTHING AND
SHOES. GET MEDICAL ATTENTION IF SYMPTOMS OCCUR. WASH CONTAMINATED
CLOTHING BEFORE RE USE. DESTROY OR THOROUGHLY CLEAN CONTAMINATED
SHOES. INGESTION: ONLY INDUCE VOMITING AT INSTRUCTION OF MEDICAL
PERSONNEL. CALL PHYSICIAN OR POISON CONTROL CENTER IMMEDIATELY.
NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON.

Flash Point:NONE
Extinguishing Media:USE APPROPRIATE AGENT FOR ADJACENT FIRE.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
PROTECTIVE CLOTHING. FIRE OR EXCESSIVE HEAT MAY PRODUCE HAZARDOUS
DECOMPOSITION PRODUCTS.
Unusual Fire/Explosion Hazard:NONE

Spill Release Procedures:FLUSH TO SEWER WITH LARGE AMOUNT OF WATER.
OTHERWISE, ABSORB SPILL WITH VERMICULITE OR OTHER INERT MATERIAL,
THEN PLACE IN A CONTAINER FOR CHEMICAL WASTE. CLEAN SURFACE
THOROUGHLY TO REMOVE RESIDUAL C ONTAMINATION.
Neutralizing Agent:NOT PROVIDED

Handling and Storage Precautions:KEEP CONTAINER CLOSED. KEEP AWAY FROM
INCOMPATIBLE SUBSTANCES (SEE INCOMPATIBILITY SECTION).
Other Precautions:AVOID CONTACT WITH EYES, SKIN, AND CLOTHING. USE WITH
ADEQUATE VENTILATION. WASH THOROUGHLY AFTER HANDLING. THE ROUTINE
USE OF NONALKALINE (ACID) TYPE OF HAND CLEANER AND REGULAR CLEANING
OF WORKING S URFACES, GLOVES, ETC. WILL HELP MINIMIZE THE
POSSIBILITY OF A SKIN REACTION.

Respiratory Protection:NONE SHOULD BE NEEDED. A RESPIRATOR SHOULD BE
WORN IF HAZARDOUS DECOMPOSITION PRODUCTS ARE LIKELY TO BE OR HAVE
BEEN RELEASED. RESPIRATOR TYPE: ACID GAS.
Ventilation:GOOD GENERAL VENTILATION (TYPICALLY 10 AIR CHANGES PER
HOUR) SHOULD BE USED. VENTILATION RATES SHOULD BE MATCHED TO
CONDITIONS.
Protective Gloves:WEAR IMPERVIOUS GLOVES AND PROTECTIVE CLOTHING
APPROPRIATE FOR RISK OF EXPOSURE
Eye Protection:WEAR SAFETY GLASSES WITH SIDE SHIELDS (OR GOGGLES).
Other Protective Equipment:EYE BATH, WASHING FACILITIES, SAFETY SHOWER.
Work Hygienic Practices:NOT PROVIDED
Supplemental Safety and Health
CONTD FROM PRODUCT ID: AND REPLENISHER. USE PROCESS ENCLOSURES, LOCAL
EXHAUST VENTILATION, OR OTHER ENGINEERING CONTROLS TO MAINTAIN
AIRBORNE LEVELS BELOW RECOMMENDED EXPOSURE LIMITS.

HCC:B3
NRC/State Lic Num:NOT RELEVANT
Boiling Pt:=100.C, 212.F
Melt/Freeze Pt:M.P/F.P Text:NOT PROVIDED
Decomp Temp:Decomp Text:NOT PROVIDED
Vapor Pres:68F: 24MBAR (18 MM HG)
Vapor Density:0.6
Spec Gravity:1.07
pH:10.8
Viscosity:NOT PROVIDED
Evaporation Rate & Reference:NOT PROVIDED
Solubility in Water:COMPLETE
Appearance and Odor:COLORLESS LIQUID - ODORLESS
Percent Volatiles by Volume:90 WT
Corrosion Rate:NOT PROVIDED

Stability Indicator/Materials to Avoid:YES
STRONG ACIDS
Stability Condition to Avoid:NOT PROVIDED
Hazardous Decomposition Products:SULFUR DIOXIDE.

Waste Disposal Methods:DISCHARGE, TREATMENT, OR DISPOSAL MAY BE SUBJECT
TO NATIONAL, STATE, OR LOCAL LAWS. FLUSH TO SEWER WITH LARGE AMOUNT
OF WATER. SINCE EMPTIED CONTAINERS RETAIN PRODUCT RESIDUE, FOLLOW
LABEL WARNINGS EV EN AFTER CONTAINER IS EMPTIED.

Toxicological Information:IN F-344 RATS, CHRONIC ORAL ADMINISTRATION OF
HYDROQUINONE HAS RESULTED IN THE FORMATION OF BENIGN KIDNEY
TUMORS THOUGHT TO BE SECONDARY TO NEPHROPATHY.
HYDROQUINONE-INDUCED NEPHROPATHY FOLLOWIN G ORAL ADMINISTRATION
HAS BEEN NOTED IN THE MALE F-344 RAT, BUT NOT IN OTHER SPECIES OR
RAT STRAINS TESTED. ALTHOUGH AN INCREASE IN MONONUCLEAR CELL
LEUKEMIA IN F-344 FEMALE RATS HAS BEEN REP ORTED FOLLOWING
CHRONIC ORAL ADMINISTRATION OF HYDROQUINONE, THIS FINDING WAS
NOT REPRODUCED IN A SUBSEQUENT STUDY.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:THE FOLLOWING PROPERTIES ARE ESTIMATED FROM THE COMPONENTS
OF THE PREPARATIONS. POTENTIAL TOXICITY: FISH LC50 MG/L: 1-10.
DAPHNID EC50 MG/L: 1-10. ALGAL IC50 MG/L: 10-100. ORGANICS
READILY DEGR ADABLE (>70%): YES (7 DAYS). POTENTIAL
BIOACCUMULATION: LOG POW <1. COD (APPROXIMATE G/L): 44. BOD5
(APPROXIMATE G/L): 29. POTENTIAL TOXICITY: WASTE TREATMENT
MICROORGANISMS EC50 (MG/L): >100.

Transport Information:FOR TRANSPORTATION INFORMATION REGARDING THIS
PRODUCT CALL THE KODAK WORLDWIDE TRANSPORTATION HAZMAT HOT LINE:
(716) 722-2400 BETWEEN 8 A.M. AND 5 P.M. (EASTERN STANDARD TIME),
MONDAY THROUGH FRIDAY .

SARA Title III Information:CHEMICAL(S) SUBJECT TO THE REPORTING
REQUIREMENTS OF SECTION 313 OR TITLE III OF THE SUPERFUND
AMENDMENTS AND REAUTHORIZATION ACT (SARA) OF 1986 AND 40 CFR
PART 372: HYDROQUINONE
Federal Regulatory Information:NOT PROVIDED
State Regulatory Information:MATERIAL(S) KNOWN TO THE STATE OF
CALIFORNIA TO CAUSE CANCER: NONE - MATERIAL(S) KNOWN TO THE STATE
OF CALIFORNIA TO CAUSE ADVERSE REPRODUCTIVE EFFECTS: NONE